REFUGE Challenge: A unified framework for evaluating automated methods for glaucoma assessment from fundus photographs.

Journal: Medical image analysis
Published Date:

Abstract

Glaucoma is one of the leading causes of irreversible but preventable blindness in working age populations. Color fundus photography (CFP) is the most cost-effective imaging modality to screen for retinal disorders. However, its application to glaucoma has been limited to the computation of a few related biomarkers such as the vertical cup-to-disc ratio. Deep learning approaches, although widely applied for medical image analysis, have not been extensively used for glaucoma assessment due to the limited size of the available data sets. Furthermore, the lack of a standardize benchmark strategy makes difficult to compare existing methods in a uniform way. In order to overcome these issues we set up the Retinal Fundus Glaucoma Challenge, REFUGE (https://refuge.grand-challenge.org), held in conjunction with MICCAI 2018. The challenge consisted of two primary tasks, namely optic disc/cup segmentation and glaucoma classification. As part of REFUGE, we have publicly released a data set of 1200 fundus images with ground truth segmentations and clinical glaucoma labels, currently the largest existing one. We have also built an evaluation framework to ease and ensure fairness in the comparison of different models, encouraging the development of novel techniques in the field. 12 teams qualified and participated in the online challenge. This paper summarizes their methods and analyzes their corresponding results. In particular, we observed that two of the top-ranked teams outperformed two human experts in the glaucoma classification task. Furthermore, the segmentation results were in general consistent with the ground truth annotations, with complementary outcomes that can be further exploited by ensembling the results.

Authors

  • José Ignacio Orlando
    Christian Doppler Laboratory for Ophthalmic Image Analysis (OPTIMA), Department of Ophthalmology, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria.
  • Huazhu Fu
    A*STAR, Singapore, Singapore.
  • João Barbosa Breda
    Surgery and Physiology Department, Ophthalmology Unit, Faculty of Medicine, University of Porto, Porto, Portugal; Research Group Ophthalmology, KU Leuven, Leuven, Belgium.
  • Karel Van Keer
    Research Group Ophthalmology, KU Leuven, Kapucijnenvoer 33, 3000 Leuven, Belgium.
  • Deepti R Bathula
    Department of Computer Science & Engineering at Indian Institute of Technology (IIT) Ropar,Rupnagar, 140001 Punjab, India.
  • Andres Diaz-Pinto
    Instituto de Investigación e Innovación en Bioingeniería, I3B, Universitat Politècnica de València, Camino de Vera s/n, 46022, Valencia, Spain. andiapin@upv.es.
  • Ruogu Fang
    J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL.
  • Pheng-Ann Heng
  • Jeyoung Kim
    Gachon University, 461-701 Gyeonggi-do, Korea.
  • Joonho Lee
    Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Joonseok Lee
    Samsung SDS AI Research Center, 06765 Seoul, Korea.
  • Xiaoxiao Li
    Yale University, 06510 New Haven, CT USA.
  • Peng Liu
    Department of Clinical Pharmacy, Dazhou Central Hospital, Dazhou 635000, China.
  • Shuai Lu
    Laboratory of Molecular Design and Drug Discovery, School of Science, China Pharmaceutical University, Nanjing, China.
  • Balamurali Murugesan
  • Valery Naranjo
    Instituto de Investigación e Innovación en Bioingeniería, I3B, Universitat Politècnica de València, Camino de Vera s/n, 46022, Valencia, Spain.
  • Sai Samarth R Phaye
    Department of Computer Science & Engineering at Indian Institute of Technology (IIT) Ropar,Rupnagar, 140001 Punjab, India.
  • Sharath M Shankaranarayana
  • Apoorva Sikka
    Department of Computer Science & Engineering at Indian Institute of Technology (IIT) Ropar,Rupnagar, 140001 Punjab, India.
  • Jaemin Son
    VUNO Inc., Seoul, Korea.
  • Anton van den Hengel
  • Shujun Wang
    Department of Immunology, Shanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Junyan Wu
    Cleerly Inc., New York, United States.
  • Zifeng Wu
    Australian Institute for Machine Learning, Australia.
  • Guanghui Xu
    South China University of Technology, Guangzhou 510006, China.
  • Yongli Xu
    Faculty of Science, Beijing University of Chemical Technology, Beijing 100029, China.
  • Pengshuai Yin
    South China University of Technology, Guangzhou 510006, China.
  • Fei Li
    Institute for Precision Medicine, Tsinghua University, Beijing, China.
  • Xiulan Zhang
    Zhongshan Ophthalmic Center, Sun Yat-sen University, China. Electronic address: zhangxl2@mail.sysu.edu.cn.
  • Yanwu Xu
    School of Future Technology, South China University of Technology, Guangzhou, Guangdong Province, China.
  • Hrvoje Bogunović
    Christian Doppler Laboratory for Ophthalmic Image Analysis (OPTIMA), Department of Ophthalmology, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria.